D89.44 Faturalandırılabilir, belirli kod Hereditary alpha tryptasemia

ICD-10-CM D89.44 identifies “Hereditary alpha tryptasemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Bölüm 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Kod talimatları

Use additional code3
  • code, if applicable, for:
  • allergy status, other than to drugs and biological substances (Z91.0-)
  • personal history of anaphylaxis (Z87.892)

Üst düzey talimatlar

Bölümler 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

D80-D89 · Certain disorders involving the immune mechanism (D80-D89)

Includes3
  • defects in the complement system
  • immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
  • sarcoidosis
Excludes 12
  • autoimmune disease (systemic) NOS (M35.9)
  • functional disorders of polymorphonuclear neutrophils (D71-)
Excludes 21

human immunodeficiency virus [HIV] disease (B20)

D89 · Other disorders involving the immune mechanism, not elsewhere classified

Excludes 12
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes 21

transplant failure and rejection (T86.-)

D89.4 · Mast cell activation syndrome and related disorders

Excludes 111
  • aggressive systemic mastocytosis (C96.21)
  • congenital cutaneous mastocytosis (Q82.2)
  • (non-congenital) cutaneous mastocytosis (D47.01)
  • (indolent) systemic mastocytosis (D47.02)
  • malignant mast cell neoplasm (C96.2-)
  • malignant mastocytoma (C96.29)
  • mast cell leukemia (C94.3-)
  • mast cell sarcoma (C96.22)
  • mastocytoma NOS (D47.09)
  • other mast cell neoplasms of uncertain behavior (D47.09)
  • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Resmî dizin referansları

Resmî dizin referansları (3)

Hereditary alpha tryptasemia(syndrome) (1)
Syndrome (1)
Tryptasemia, hereditary alpha (1)

Resmî dönüşüm geçmişi

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Geçerlilik tarihleri 2021-10-01

Önceki atama: D89.49

Geçmiş

Kod geçmişi

Son kaydedilen değişiklik · FY2027

DeğiştiDeğişmedi
FY2027Seçili sürüm

Yürürlük tarihi

  • Üst yönergeler değişti

Hereditary alpha tryptasemia

Faturalanabilir tanı kodu

CDC/NCHS · FY2027

Tüm sürümler (11)

Tüm sürümlerYürürlük tarihiKod geçmişi
FY20222021-10-01Eklendi
FY2022 · 04-012022-04-01Tabloda değişiklik yok
FY20232022-10-01Tabloda değişiklik yok
FY2023 · 04-012023-04-01Tabloda değişiklik yok
FY20242023-10-01Tabloda değişiklik yok
FY2024 · 04-012024-04-01Tabloda değişiklik yok
FY20252024-10-01Tabloda değişiklik yok
FY2025 · 04-012025-04-01Tabloda değişiklik yok
FY20262025-10-01Üst yönergeler değişti
FY2026 · April2026-04-01Tabloda değişiklik yok
FY20272026-10-01Üst yönergeler değişti

Bu girdi, seçilen sürümde tam bir koddur. Referans kontrolü klinik uygunluğu belirlemez veya geri ödemeyi garanti etmez.